{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:58:26Z","timestamp":1793228306444,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"\n Background<\/jats:title>\n Colorectal cancer (CRC) is the primary driver of cancer-related death and illness across the world. Despite the full-scale shift of the treatment approach for some colorectal cancer patients due to the use of immune checkpoint inhibitors (ICIs), primary resistance still poses a huge challenge to clinicians. Bile acid metabolism is involved in the pathogenesis of CRC. However, its particular function in shaping the tumor immune microenvironment (TIME) and its effect on prognosis and immune treatment response remain unclear.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Based on the transcriptome and clinical data from The Cancer Genome Atlas-Colon Adenocarcinoma (TCGA-COAD) cohort, we performed unsupervised consensus clustering and classified patients into different molecular subtypes according to bile acid metabolism. We subsequently compared overall survival (OS), immune cell infiltration levels, and differentially expressed genes among the subtypes. In addition, protein\u2013protein interaction (PPI) network and Cox proportional hazards regression were used to identify key hub genes. Finally, the expression of these crucial hub genes was validated in the Gene Expression Omnibus (GEO) cohort and independent clinical patients.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The bile-low group showed a significant reduction in OS time (\n p<\/jats:italic>\n = 0.0049). The infiltration levels of CD8\n +<\/jats:sup>\n T cells (\n p<\/jats:italic>\n &lt; 0.05) and M1 macrophages (\n p<\/jats:italic>\n &lt; 0.01) were significantly higher in the bile-low group than in the bile-high group. We identified three key genes\u2014\n CLCA1<\/jats:italic>\n ,\n UGT2A3<\/jats:italic>\n , and\n ZG16<\/jats:italic>\n \u2014and found that they all were downregulated in tumor tissues across the TCGA-COAD and GEO datasets, as well as in independent clinical samples. Survival analysis showed that high\n CLCA1<\/jats:italic>\n expression was significantly associated with favorable overall survival (\n p<\/jats:italic>\n &lt; 0.001), whereas\n UGT2A3<\/jats:italic>\n (\n p<\/jats:italic>\n = 0.23) and\n ZG16<\/jats:italic>\n (\n p<\/jats:italic>\n = 0.17) did not reach statistical significance. The three hub genes were negatively correlated with the (TIDE) score (\n CLCA1<\/jats:italic>\n :\n R<\/jats:italic>\n = \u2212 0.24,\n p<\/jats:italic>\n &lt; 0.001;\n UGT2A3<\/jats:italic>\n :\n R<\/jats:italic>\n = \u2212 0.15,\n p<\/jats:italic>\n = 0.0022;\n ZG16<\/jats:italic>\n :\n R<\/jats:italic>\n = \u2212 0.14,\n p<\/jats:italic>\n = 0.0039).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n Our findings suggest that bile acid metabolism could shape the TIME via key genes\n CLCA1<\/jats:italic>\n ,\n UGT2A3<\/jats:italic>\n , and\n ZG16<\/jats:italic>\n , and subsequently modify CRC prognosis and immunotherapy responses. These genes may serve as potential prognostic indicators and mechanistic mediators linking bile acid metabolism to T-cell dysfunction, offering insights for future combination strategies targeting the metabolism\u2013barrier\u2013immunity axis.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fonc.2025.1739534","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:38:58Z","timestamp":1768196338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative subtyping by bile acid metabolism identifies CLCA1\/UGT2A3\/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Li","family":"Feng","sequence":"first","affiliation":[{"name":"Department of General Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeXin","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Plastic and Aesthetic Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Mao","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA-A Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21838","article-title":"Global cancer statistics: A healthy population relies on population health","volume":"74","author":"Jokhadze","year":"2024","journal-title":"CA-A Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: A general overview and future perspectives in colorectal cancer","volume":"18","author":"M\u00e1rmol","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejca.2023.03.029","article-title":"Tumour mutational burden as a biomarker in patients with mismatch repair deficient\/microsatellite instability- high metastatic colorectal cancer treated with immune checkpoint inhibitors","volume":"187","author":"Manca","year":"2023","journal-title":"Eur J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01317-7","article-title":"Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades","volume":"20","author":"Li","year":"2021","journal-title":"Mol Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02179-5","article-title":"Current trends in sensitizing immune checkpoint inhibitors for cancer treatment","volume":"23","author":"Wei","year":"2024","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.629722","article-title":"Tumor burden and immunotherapy: impact on immune infiltration and therapeutic outcomes","volume":"11","author":"Kim","year":"2021","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-024-00914-3","article-title":"The changing metabolic landscape of bile acids-keys to metabolism and immune regulation","volume":"21","author":"Mohanty","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142964","article-title":"New insights into bile acids related signaling pathways in the onset of colorectal cancer","volume":"14","author":"Caliceti","year":"2022","journal-title":"Nutrients"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000450907","article-title":"Disease-associated changes in bile acid profiles and links to altered gut microbiota","volume":"35","author":"Joyce","year":"2017","journal-title":"Dig Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Rezen","year":"2022","journal-title":"Cell And Mol Life Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.813745","article-title":"Secondary bile acids and tumorigenesis in colorectal cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Front In Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2860","article-title":"western diet deregulates bile acid homeostasis, cell proliferation, and tumorigenesis in colon","volume":"77","author":"Dermadi","year":"2017","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01865-z","article-title":"The effects of metabolism on the immune microenvironment in colorectal cancer","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-024-01049-z","article-title":"PD-L1 expression in colorectal carcinoma correlates with the immune microenvironment","volume":"55","author":"Shahin","year":"2024","journal-title":"J GI Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.884839","article-title":"Tumor microenvironment heterogeneity-based score system predicts clinical prognosis and response to immune checkpoint blockade in multiple colorectal cancer cohorts","volume":"9","author":"Wang","year":"2022","journal-title":"Front In Mol Biosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.784199","article-title":"Immune landscape refines the classification of colorectal cancer with heterogeneous prognosis, tumor microenvironment and distinct sensitivity to frontline therapies","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.792691","article-title":"The role of the tumor microenvironment and treatment strategies in colorectal cancer","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020631","article-title":"The impact of food additives on the abundance and composition of gut microbiota","volume":"28","author":"Zhou","year":"2023","journal-title":"Molecules"},{"key":"B23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3. 0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 years and still GOing strong","volume":"47","author":"Carbon","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141931","article-title":"Reduced tumor-antigen density leads to PD-1\/PD-L1-mediated impairment of partially exhausted CD8+T cells","volume":"42","author":"Kaiser","year":"2012","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05418-x","article-title":"Spatial distribution pattern of immune cells is associated with patient prognosis in colorectal cancer","volume":"22","author":"Shen","year":"2024","journal-title":"J Of Trans Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-00670-3","article-title":"Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review","volume":"13","author":"He","year":"2020","journal-title":"J Ovarian Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.045500","article-title":"Novel polymorphic human UDP-glucuronosyltransferase 2A3: Cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction","volume":"74","author":"Court","year":"2008","journal-title":"Mol Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283330767","article-title":"Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3","volume":"19","author":"Sneitz","year":"2009","journal-title":"Pharmcog Genomics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13435","article-title":"Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5721","article-title":"G-quadruplex-enhanced circular single-stranded DNA (G4-CSSD) adsorption of miRNA to inhibit colon cancer progression","volume":"12","author":"Wu","year":"2023","journal-title":"Cancer Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2019.05.001","article-title":"Characterization of human UGT2A3 expression using a prepared specific antibody against UGT2A3","volume":"34","author":"Gotoh-Saito","year":"2019","journal-title":"Drug Metab Pharmacokinet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.812596","article-title":"Association between gut microbiota and osteoarthritis: A review of evidence for potential mechanisms and therapeutics","volume":"12","author":"Wei","year":"2022","journal-title":"Front Cell Infect Microbiol"}],"updated-by":[{"DOI":"10.3389\/fonc.2026.1964466","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1739534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:02:07Z","timestamp":1787828527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1739534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":39,"alternative-id":["10.3389\/fonc.2025.1739534"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1739534","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1739534"}}